Get startedLog in
    Picture of ADC Therapeutics SA logo

    ADCT — ADC Therapeutics SA Income Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapMomentum Trap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for ADC Therapeutics SA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

    2021
    December 31st
    R2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    2025
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:20-F10-K10-K10-K10-K
    Standards:
    IFRS
    USG
    USG
    USG
    USG
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue33.921069.670.881.4
    Cost of Revenue
    Gross Profit32.52076764.975.6
    Selling / General / Administrative Expenses
    Research And Development
    Depreciation and Amortization
    Unusual Expense / Income
    Total Operating Expenses296375236201203
    Operating Profit-262-165-166-131-121
    Total Net Non Operating Interest Income / Expense
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes-252-147-195-156-142
    Provision for Income Taxes
    Net Income After Taxes-230-147-235-156-143
    Equity in Affiliates
    Net Income Before Extraordinary Items
    Net Income-230-157-240-158-143
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income-230-157-240-158-143
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS-3.07-1.66-2.94-1.62-1.06